Q4 2018 Holdings
Filed 2019-02-13 | 45 holdings | $347.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ascendis Pharma A/S(ASND) | ADR | 04351P101 | $135.8M | 2,166,832 | 39.1% |
| Crinetics Pharmaceuticals Inc(CRNX) | Common | 22663K107 | $113.7M | 3,792,169 | 32.7% |
| Codexis, Inc(CDXS) | Common | 192005106 | $45.3M | 2,714,458 | 13.1% |
| Arrowhead Pharmaceuticals Inc(ARWR) | Common | 04280A100 | $28.9M | 2,328,475 | 8.3% |
| Aclaris Therapeutics, Inc.(ACRS) | Common | 00461U105 | $12.2M | 1,647,214 | 3.5% |
| Aurinia Pharmaceuticals Inc.(AUPH) | Common | 05156V102 | $8.3M | 1,213,290 | 2.4% |
| Arvinas Holding Co LLC(ARVN) | Common | 04335A105 | $2.7M | 209,666 | 0.8% |
| Biohaven Pharmaceutical Holding Company Ltd(BHVN) | Common | G11196105 | $67.1K | 1,813,340 | 0.0% |
| Sinovac Biotech Ltd.(SVA) | SHS | P8696W104 | $40.9K | 5,900,000 | 0.0% |
| KalVista Pharmaceuticals Inc.(KALV) | Common | 483497103 | $26.8K | 1,359,149 | 0.0% |
| Homology Medicines, Inc. | Common | 438083107 | $25.9K | 1,159,742 | 0.0% |
| Kadmon Holdings Inc(KDMN) | Common | 48283N106 | $21.7K | 10,454,545 | 0.0% |
| Amyris, Inc(AMRSEUR) | Common | 03236M200 | $18.6K | 5,575,785 | 0.0% |
| Tricida, Inc.(1T7) | Common | 89610F101 | $18.4K | 781,185 | 0.0% |
| Eiger BioPharmaceuticals Inc(CLDNEUR) | Common | 28249U105 | $18.2K | 1,791,257 | 0.0% |
| Menlo Therapeutics Inc. | Common | 586858102 | $16.5K | 4,011,236 | 0.0% |
| MEI Pharma Inc | Common | 55279B202 | $15.3K | 5,778,106 | 0.0% |
| Iovance Biotherapeutics, Inc.(IOVA) | Common | 462260100 | $14.2K | 1,600,000 | 0.0% |
| Verona Pharma PLC(VRNA) | ADS | 925050106 | $13.4K | 1,492,951 | 0.0% |
| Orchard Therapeutics plc | ADS | 68570P101 | $12.8K | 811,894 | 0.0% |
| Obseva SA | Common | H5861P103 | $11.9K | 937,147 | 0.0% |
| Acer Therapeutics Inc(OPXAEUR) | Common | 00444P108 | $11.7K | 579,051 | 0.0% |
| Apellis Pharmaceuticals, Inc.(APLS) | Common | 03753U106 | $11.5K | 874,573 | 0.0% |
| Mirati Therapeutics Inc.(MRTXEUR) | Common | 60468T105 | $10.7K | 251,107 | 0.0% |
| Nabriva Therapeutics AG | SHS | G63637105 | $9.7K | 6,619,190 | 0.0% |
| Zymeworks Inc | Common | 98985W102 | $9.1K | 620,134 | 0.0% |
| Xenon Pharmaceuticals Inc(XENE) | Common | 98420N105 | $8.9K | 1,405,476 | 0.0% |
| Soleno Therapeutics, Inc. | Common | 834203200 | $7.5K | 4,359,683 | 0.0% |
| Kiniksa Pharmaceuticals | Common | G5269C101 | $7.4K | 264,878 | 0.0% |
| Cymabay Therapeutics Inc(CBAYUSD) | Common | 23257D103 | $7.1K | 906,000 | 0.0% |
| Galmed Pharmaceuticals Ltd(GLMD) | SHS | M47238106 | $6.6K | 971,337 | 0.0% |
| Kala Pharmaceuticals, Inc. | Common | 483119103 | $5.1K | 1,043,020 | 0.0% |
| Zogenix, Inc. | Common | 98978L204 | $3.8K | 105,000 | 0.0% |
| Sierra Oncology, Inc | Common | 82640U107 | $3.2K | 2,438,270 | 0.0% |
| Genocea Biosciences Inc | Common | 372427104 | $2.3K | 8,180,000 | 0.0% |
| Zai Lab Limited(ZLAB) | ADR | 98887Q104 | $1.9K | 81,819 | 0.0% |
| BioPharmX Corporation | Common | 09072X101 | $1.7K | 16,128,515 | 0.0% |
| DBV Technologies S.A. | ADR | 23306J101 | $1.7K | 269,995 | 0.0% |
| Selecta Biosciences Inc(SELBUSD) | Common | 816212104 | $1.5K | 546,054 | 0.0% |
| Agile Therapeutics, Inc.(AGRXUSD) | Common | 00847L100 | $872 | 1,513,975 | 0.0% |
| Trevena, Inc. | Common | 89532E109 | $743 | 1,728,000 | 0.0% |
| Foamix Pharmaceuticals Ltd. | SHS | M46135105 | $723 | 201,478 | 0.0% |
| Akari Therapeutics Plc | ADR | 00972G108 | $543 | 345,850 | 0.0% |
| Sunesis Pharmaceuticals, Inc. | Common PAR | 867328700 | $81 | 195,474 | 0.0% |
| Soleno Therapeutics, Inc. | Warrant | 834203135 | $19 | 188,772 | 0.0% |